ProMIS Neurosciences Inc PMN

IMMUSAFE.COM

[TopBroker]

This was sent to me by one of your shareholders and a question why this was not disclosed to the shareholders as a news release on the state of the Companies ongoing joint venture. SEC rules are specific as to disclosure and I find it reprehensible that your over paid, under qualified management does not look after the shareholders best interest. There must be a reason to keep this stock from underperforming. You need a board change badly.

https://immusafe.com/

[DavidKingCanada]

Please keep in mind PMN is searching for a new CEO by years end. There will be more changes coming to upper Managment. At the current price this Company is a Buy and Hold for now. Don't worry too much about the few cents up and down. If and when Aducanumb is approved, this Stock will go up. 

[Mole101]

Wow !! I see it as a great progress and a source of future revenue for PMN , the website it's not finished and no sales are taking place at this time, likely they are not ready to go and waiting for few more approvals.  I see it as proactive and looks like it's run by BCNI do it will be ontheir time frame and ones ready   

[M101]

Finally,, something which Goldstein can't FUp

[M101]

Isn't that just putting a brand name to the JV announced last year?

[goldtech]

I read all the approvals are complete and talking to their lab sales have been brisk.

[M101]

Must be pro sports teams and business class passengers https://immusafe.com/pricing/

[BrokenPromis]

Sorry I just saw this website.  What technology/IP is from Promis?   Surface PlasmonResonance? Do we know this isn't all BCNL's development?

[Mole101]

b) Joint arrangement 2 (JV2) will provide the service of highly sensitive and specific serological assays for the detection and characterization of antibodies to the SARS-CoV-2 virus that is responsible for COVID-19. JV2 includes a jointly controlled venture (Immusafe Labs, Inc.) and jointly controlled operations. The company acquired 50% of Immusafe Labs, Inc. for $3,000. The company is

[DavidKingCanada]

This is great news for the future of PMN

[M101]

[BrokenPromis]

M101 - I bought into the "Promise" of best-in-class a couple of years ago.  I have what for me is a lot of money in this company.  Some of it as high as $0.42 usd.  I used to believe them when they talked about clinical trials.  I was also excited when they talked about the JV.  But the absolute reality is that the ONLY delivery so far has been a dilution. 

[M101]

I share your skepticism, but it should be obvious to any investor (not traders) that SPR is a technology that could not possibly have come from Promis.  

[BrokenPromis]

Yeah, that was kind of the point i was trying to make.  I did not see anything on that website that pointed me to something Promis had contributed.  I am assuming it is in there - that it is Promis IP that is differentiating what they are doing.  But I did not see any mention of propriatary technology based on what we are doing...

[M101]

See news released 2020 May 19 & 28, and  June 17. I include May 28, the supercluster award for Plotkin's work on covid evolution only because it seems logical that the JV is going to want to stay ahead of the curve re variants.   

[Speyeder999]

Speaking of Plotkin, does anyone know if he's still on Promis's management team?I think a poster alluded to the fact that he is no longer on board. That would strike me as strange, no? Furthermore, unless I'm mistaken, I find it odd that he doesn't appear to be holding any shares of the company (again, I may be mistaken on this) but I seem to be notice everyone else as owning

[Mole101]

  https://promisneurosciences.com/team/ Steven Plotkin, PhD Chief Physics Officer Prof. Steven Plotkin is a theoretical and computational biophysicist whose research focuses on protein folding and misfolding in neurodegenerative disease, protein evolution and cellular differentiation, and the molecular mechanisms of cancer. He has been a professor at UBC in the Department of Physics

[Speyeder999]

Thanks Mole,  Anyway of finding out if he's still a shareholder. Reason I'm asking is James Kupiec seemed to have exited as our Chief Medical Officer without a mention last December without a mention from the company nor a mention in the year end report to become Chief Clinical Developer at Cassava. He seems to be holding on the 2,5 millions shares or so, unlesss he unloaded them

[Gbathat]

TB, thanks for sharing this!!!!!!   Hopefully we get a PR soon.  This looks very exciting.

[Gbathat]

I think there will be high demand for this test.  IgG sub-classes... nice. Also, check out the example report at https://immusafe.com/our-technology/  (scroll down and click on pdf window to see the report).  It tells you your avidity to different variants and provides travel recommendations. Talk about timely.

[Normandt1965]

I followed the link this morning and it worked....but now it's password protected. ////////// I think there will be high demand for this test. IgG sub-classes... nice. Also, check out the example report at https://immusafe.com/our-technology/ (scroll down and click on pdf window to see the report). It tells you your avidity to different variants and provides travel recommendations. Talk about

[BottomBroker]

So now wait a second here. Does this mean Promis may start to generate....revenue??? Things are getting interesting. 

[Gbathat]

at about $160 per test, given the current price on the website and the planned a 50-50 split between PMN and BCNI I wonder if they are keeping this quiet due to potential ongoing non-exclusive licensing negotiations.   If the market for this type of analysis is as big as I hope, and especially if insurance covers these tests in some or all cases, they would need more than one lab

[Gbathat]

correction: $197.50/ test, as each test cost $395USD